3-Bromobenzo[d]isoxazole

Catalog No.: 
ACZRSO594
CAS No.: 
1263178-34-2
Molecular Formula: 
C7H4BrNO
Molecular Weight: 
198.02
3-Bromobenzo[d]isoxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$110.00In stockInquiry
250mg95%$209.00In stockInquiry
1g95%$560.00In stockInquiry
5g95%$1378.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromobenzo[d]isoxazole
IUPAC Name3-bromobenzo[d]isoxazole
MDL No.MFCD18792895
Molecular FormulaC7H4BrNO
Molecular Weight198.02
SMILESBrC1=NOC2=C1C=CC=C2
InChI KeyNCIYIIPYKCJIPS-UHFFFAOYSA-N
Synonym3-BroMobenzo[d]isoxazole;3-bromo-1,2-benzoxazole;1,2-Benzisoxazole, 3-bromo-
CAS No.1263178-34-2
PubChem CID69245316

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACZRSO594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHKBW863 route compound structure diagram
    ACHKBW863611-20-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZRSO594 route product structure diagram
    ACZRSO5941263178-34-2In Stock
Inquiry

2. ACZRSO594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHKBW863 route compound structure diagram
    ACHKBW863611-20-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZRSO594 route product structure diagram
    ACZRSO5941263178-34-2In Stock
Inquiry

3. ACZRSO594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHKBW863 route compound structure diagram
    ACHKBW863611-20-1In Stock
  4. Then
  5. ACZRSO594 route product structure diagram
    ACZRSO5941263178-34-2In Stock
Inquiry

Comments (0)